Metraipolis › archive › dc_1e2b60c80267

A platform approach as a plausible option for nonclinical safety assessment of adjuvanted vaccines — Europe PMC PMID:40804241

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40804241
DOI
10.1038/s41541-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-10T15:39:32.809Z
SHA-256 of the archived text
82f8b848d7ceb15340168c9e5f6be354975e349065c3cfd723c804860e733aa4
Stable URL of this page
https://metraipolis.com/documento/dc_1e2b60c80267

How to cite

A platform approach as a plausible option for nonclinical safety assessment of adjuvanted vaccines — Europe PMC PMID:40804241 — Europe PMC (en), https://europepmc.org/article/MED/40804241 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1e2b60c80267 (Metraipolis archive dc_1e2b60c80267, sha256 82f8b848d7ceb15340168c9e5f6be354975e349065c3cfd723c804860e733aa4)
BibTeX
@misc{dc1e2b60c80267,
  title = {A platform approach as a plausible option for nonclinical safety assessment of adjuvanted vaccines — Europe PMC PMID:40804241},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40804241},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1e2b60c80267; sha256 82f8b848d7ceb15340168c9e5f6be354975e349065c3cfd723c804860e733aa4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40804241. Agents can read the archived copy with the MCP tool read_document.